Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin continuation versus discontinuation around coronary angiography
IRCT20200201046329N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Lactic acidosis, Plasma lactic acid level and 1 more. Started Dec 2018; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20200201046329N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200201046329N1.